CTRI/2012/04/002545招募中4 期
A randomized placebo controlled trial evaluating the safety and efficacy of rTMS in migraine prophylaxis
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients of migraine headache with frequency of attacks more than four attcaks per month.
排除标准
- •Pregnancy, liver or kidney diseases, malignancy, severe hypertension, pacemaker or metallic implants and history of seizure or structural brain lesions
研究者
相似试验
尚未招募
Unknown
A study to see the effect of calcium and vitamin D supplementation on the progression of dengue fever to dengue shock syndrome and dengue hemorrhagic fever,CTRI/2024/05/066756MILIND RAJ NAGVANSHI
已完成
Unknown
Placebo-controlled, randomized trial to evaluate the intestinal environments by the continuous supplementation of apple polyphenolsJPRN-UMIN000052400Food Research Institute, National Agriculture and Food Research Organization68
尚未招募
3 期
Effect of homoeopathic medicine angustura vera in osteoarthritisCTRI/2022/05/042891Dr Girendra Pal Homoeopathic Hospital and Research Centre
进行中（未招募）
1 期
A study to examine the safety, tolerability and effects on abnormal bone formation of REGN2477 in patients with Fibrodysplasia Ossificans ProgressivaFibrodysplasia Ossificans Progressiva (FOP)MedDRA version: 20.0Level: PTClassification code 10068715Term: Fibrodysplasia ossificans progressivaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2016-005035-33-ITREGENERON PHARMACEUTICALS, INC.44
进行中（未招募）
1 期
A study to examine the safety, tolerability and effects on abnormal bone formation of REGN2477 in patients with Fibrodysplasia Ossificans ProgressivaFibrodysplasia Ossificans Progressiva (FOP)MedDRA version: 20.0Level: PTClassification code 10068715Term: Fibrodysplasia ossificans progressivaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2016-005035-33-GBRegeneron Pharmaceuticals, Inc.40